• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Molecular and immune biomarker testing in squamous-cell lung cancer: effect of current and future therapies and technologies.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    PIIS1525730418300561.pdf
    Size:
    393.5Kb
    Format:
    PDF
    Description:
    Full text, Open Access article
    Download
    Authors
    Hirsch, F
    Kerr, K
    Bunn, P
    Kim, E
    Obasaju, C
    Pérol, M
    Bonomi, P
    Bradley, J
    Gandara, D
    Jett, J
    Langer, C
    Natale, R
    Novello, S
    Paz-Ares, L
    Ramalingam, S
    Reck, M
    Reynolds, C
    Smit, E
    Socinski, M
    Spigel, D
    Stinchcombe, T
    Vansteenkiste, J
    Wakelee, H
    Thatcher, Nick
    Show allShow less
    Affiliation
    Division of Medical Oncology, University of Colorado Cancer Center, Aurora, CO.
    Issue Date
    2018-07
    
    Metadata
    Show full item record
    Abstract
    Patients with non-small-cell lung cancer, including squamous-cell lung cancer (SqCLC), typically present at an advanced stage. The current treatment landscape, which includes chemotherapy, radiotherapy, surgery, immunotherapy, and targeted agents, is rapidly evolving, including for patients with SqCLC. Prompt molecular and immune biomarker testing can serve to guide optimal treatment choices, and immune biomarker testing is becoming more important for this patient population. In this review we provide an overview of current and emerging practices and technologies for molecular and immune biomarker testing in advanced non-small-cell lung cancer, with a focus on SqCLC.
    Citation
    Molecular and immune biomarker testing in squamous-cell lung cancer: effect of current and future therapies and technologies. 2018, 19(4): 331-339 Clin Lung Cancer
    Journal
    Clinical Lung Cancer
    URI
    http://hdl.handle.net/10541/621096
    DOI
    10.1016/j.cllc.2018.03.014
    PubMed ID
    29773328
    Type
    Article
    Language
    en
    ISSN
    1938-0690
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.cllc.2018.03.014
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Emerging drugs for squamous cell lung cancer.
    • Authors: Cheng H, Shcherba M, Kandavelou K, Liang Y, Liu H, Perez-Soler R
    • Issue date: 2015 Mar
    • [Progress on the Study of Targeting FGFR in Squamous Non-small Cell Lung Cancer].
    • Authors: Dong M, Li T, Chen J
    • Issue date: 2018 Feb 20
    • [PD-L1 expression: An emerging biomarker in non-small cell lung cancer].
    • Authors: Adam J, Planchard D, Marabelle A, Soria JC, Scoazec JY, Lantuéjoul S
    • Issue date: 2016 Jan
    • [Research status on molecular targeted therapy for squamous-cell lung cancer].
    • Authors: Li Y, Zhou Y, Wang H
    • Issue date: 2014 Aug 20
    • Best practice in the treatment of advanced squamous cell lung cancer.
    • Authors: Ang YL, Tan HL, Soo RA
    • Issue date: 2015 Oct
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.